Pay in 4 interest-free payments of $6.17 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Recently, LEADER (Liraglutide Effect and Action in Diabetes: Evaluation of cardiovascular outcome Results) study shows that GLP-1 analogue liraglutide treatment reduces the rates of cardiovascular events and death in patients with type 2 diabetes 9
Poiares-Baptista A, Tellechea O, Reis JP, et al
7,9 Although GLP1 RA-based therapies can play an important role in T2D and weight management, they should not be prescribed without a comprehensive lifestyle intervention
The GLP-1 Booster concept does not rely on synthetic drugsit instead amplifies the bodys innate appetite-regulating mechanisms through a synergistic combination of soluble fibers, botanicals, and nutrient cofactors
US$ 26.63
US$ 27.43
US$ 27.77
US$ 23.98
